Replies to post #4269 on Momenta Pharmaceuticals, Inc. (MNTA)

[DewDiligence]

Rough breakdown of US Lovenox sales during 1Q11 by product and market segment:

 
                      -$ Sales (mln)-   -----Share----- 
                      Branded Generic   Branded Generic 
 Hospital segment       234     100       70%     30% 
 Outpatient segment      76     147       35%     65% 
 ==================     ===     === 
 Overall market         310     247       56%     44%

Generic Lovenox’s share in both markets segments rose in Mar 2011, so the 2Q11 breakdown ought to be considerably better for the generic than the 1Q11 numbers.